Somatostatin Receptor Imaging with [

PET [18F]FET-βAG-TOCA [68Ga]Ga-DOTA-peptide neuroendocrine tumors somatostatin receptor

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
08 Feb 2024
Historique:
received: 22 09 2023
revised: 19 12 2023
medline: 9 2 2024
pubmed: 9 2 2024
entrez: 8 2 2024
Statut: aheadofprint

Résumé

There is a clinical need for

Identifiants

pubmed: 38331457
pii: jnumed.123.266601
doi: 10.2967/jnumed.123.266601
pmc: PMC10924162
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/J007986/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N020782/1
Pays : United Kingdom

Informations de copyright

© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Références

J Nucl Med. 2016 Aug;57(8):1207-13
pubmed: 27173162
J Clin Oncol. 2008 Jun 20;26(18):3063-72
pubmed: 18565894
J Clin Oncol. 2016 Feb 20;34(6):588-96
pubmed: 26712231
Neuroendocrinology. 2009;90(2):162-6
pubmed: 19060454
Mol Imaging Biol. 2011 Jun;13(3):583-593
pubmed: 20652423
J Nucl Med. 2011 Sep;52(9):1441-8
pubmed: 21852355
Bioorg Med Chem Lett. 2011 May 15;21(10):3122-7
pubmed: 21458258
Nucl Med Commun. 2014 Jun;35(6):613-9
pubmed: 24686250
Lancet Oncol. 2006 Sep;7(9):728-34
pubmed: 16945767
J Nucl Med. 2013 Mar;54(3):364-72
pubmed: 23297077
J Nucl Med. 2011 Dec;52(12):1864-70
pubmed: 22072704
J Nucl Med. 2017 Mar;58(3):451-457
pubmed: 27660147
JAMA Oncol. 2017 Oct 01;3(10):1335-1342
pubmed: 28448665
Radiother Oncol. 2019 Dec;141:108-115
pubmed: 31542317
Ann Oncol. 2020 Jul;31(7):844-860
pubmed: 32272208
Crit Rev Oncol Hematol. 2009 Sep;71(3):199-213
pubmed: 19362010
J Nucl Med. 2023 Apr;64(4):632-638
pubmed: 36265911
N Engl J Med. 2017 Jan 12;376(2):125-135
pubmed: 28076709

Auteurs

Suraiya Dubash (S)

Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Tara D Barwick (TD)

Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Department of Imaging, Imperial College Healthcare NHS Trust, London, United Kingdom.

Kasia Kozlowski (K)

Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Andrea G Rockall (AG)

Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Sairah Khan (S)

Department of Imaging, Imperial College Healthcare NHS Trust, London, United Kingdom.

Sameer Khan (S)

Department of Imaging, Imperial College Healthcare NHS Trust, London, United Kingdom.

Siraj Yusuf (S)

Radiology and Nuclear Medicine Department, Royal Marsden NHS Foundation Trust, London, United Kingdom.

Angela Lamarca (A)

Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.

Juan W Valle (JW)

Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.

Richard A Hubner (RA)

Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.

Mairéad G McNamara (MG)

Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.

Andrea Frilling (A)

Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Tricia Tan (T)

Department of Endocrinology, Imperial College Healthcare NHS Trust, London, United Kingdom.

Florian Wernig (F)

Department of Endocrinology, Imperial College Healthcare NHS Trust, London, United Kingdom.

Jeannie Todd (J)

Department of Endocrinology, Imperial College Healthcare NHS Trust, London, United Kingdom.

Karim Meeran (K)

Department of Endocrinology, Imperial College Healthcare NHS Trust, London, United Kingdom.

Bhavesh Pratap (B)

Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Saleem Azeem (S)

Invicro-London, Imperial College London, London, United Kingdom; and.

Michael Huiban (M)

Invicro-London, Imperial College London, London, United Kingdom; and.

Nicholas Keat (N)

Invicro-London, Imperial College London, London, United Kingdom; and.

Jingky P Lozano-Kuehne (JP)

Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Population Health Sciences Institute, Faculty of Medical Sciences, University of Newcastle, Newcastle, United Kingdom.

Eric O Aboagye (EO)

Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Rohini Sharma (R)

Department of Surgery and Cancer, Imperial College London, London, United Kingdom; r.sharma@imperial.ac.uk.

Classifications MeSH